Research Shows Potential for Emergence of New Ebola Virus That Causes Disease in Humans

Article

New research at the University of Kent has highlighted the potential for the emergence of a new form of Ebola virus. A team from the university's School of Biosciences examined the differences between Ebola viruses that cause severe disease in humans and the Reston virus that does not.

The Reston virus, which is known to circulate in domestic pigs in Asia and occasionally infect humans, is currently the only member of the Ebola virus family not to have been reported as causing life-threatening disease in humans.

Using computational analysis of the sequences of the genomes of Ebola viruses and a computational prediction of the effects of sequence variations on virus function, the researchers, Dr. Mark Wass, senior lecturer in computational biology, professor Martin Michaelis, professor of molecular medicine, and Dr. Jeremy Rossman, lecturer in virology, and their teams, identified characteristic differences in a number of virus proteins.

The results suggested that only a few changes in one Ebola virus protein, VP24, may be necessary to render the Reston virus into a virus that can cause human disease. There may be a risk therefore that Reston viruses acquire the few mutations necessary to cause disease in humans and to develop into a novel health threat.

The research, "Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses," is published in Scientific Reports.

Source: University of Kent

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.